Glucocorticoid sensitivity and proinflammatory cytokines pattern in pemphigus

Journal of Clinical Immunology

Volumn 32, Issue 4, 2012, Pages 786-793

  Chriguer, Rosangela Soares ^a   Roselino, Ana Maria ^a   De Castro, Margaret ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Glucocorticoid receptor; Glucocorticoid sensitivity; Pemphigus

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CONCANAVALIN A; CYTOKINE; DAPSONE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; BINDING SITES; CONCANAVALIN A; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PEMPHIGUS; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84863985417     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9679-y     Document Type: Article

References (46)

1. Grando SA. Pemphigus autoimmunity: Hypotheses and realities. Autoimmunity. 2011. Sep 23. [Epub ahead of print].
2. Ahmed AR, Graham J, Jordan RE, Provost TT. Pemphigus: Current concepts. Ann Intern Med. 1980;92:396-405. (Pubitemid 10150476)
3. Shimizu H, Masunaga T, Ishiko A, Kikuchi A, Hashimoto T, Nishikawa T. Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding pattern to Extracellular regions of desmosomes in different layers of human epidermis. J Invest Dermatol. 1995;105:153-59.
4. Amagai M, Klaus-Kovtum V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991;67:869-77. (Pubitemid 121001501)
5. Koulu L, Kusumi A, Steinberg MS, Klaus-Kovtun V, Stanley JR. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med. 1984;160:1509-18. (Pubitemid 15220779)
6. Stanley JR, Koulu L, Klaus-Kovtum V, Steinberg MS. A monoclonal antibody to the desmosomal glycoprotein desmoglein 1 binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol. 1986;136:1227-30. (Pubitemid 16156220)
7. Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58:1043-46.
8. Chiossi MP, Roselino AM. Endemic Pemphigus foliaceus ("Fogo selvagem"): A series from the Northeastern region of the State of São Paulo, Brazil, 1973-1998. Rev Inst Med Trop SP. 2001;43:59-62. (Pubitemid 33622289)
9. Zuccolotto I, RoselinoAM, Ramalho LN, Zucoloto S. Apoptosis and p63 expression in the pathogenesis of bullous lesions of endemic pemphigus foliaceus. Arch Dermatol Res. 2003;295:284-86. (Pubitemid 38058230)
10. Chiossi MP, Costa RS, Roselino AM. Dermal dendritic cell number correlates with serum autoantibody titers in Brazilian pemphigus foliaceus patients. Braz J Med Biol Res. 2004;37:337-41. (Pubitemid 38444521)
11. Rosatelli TB, Roselino AM, Dellalibera-Joviliano R, Reis ML, Donadi EA. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvage). Br J Dermatol. 2005;152:650-57. (Pubitemid 40571295)
12. Zhu H, Chen Y, Zhou Y, Wang Y, Zheng J, Pan M. Cognate Th2-B cell interaction is essential for the autoantibodies production in pemphigus vulgaris. J Clin Immunol. 2012;32:114-23.
13. D'Auria L, Bonifati C, Mussi A, D'Agosto G, De Simone C, Giacalone B, et al. Cytokines in the sera of patients with pemphigus vulgaris: Interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytokine Netw. 1997;8:383-87. (Pubitemid 28031326)
14. Rocha-Rodrigues DB, Paschoini G, Pereira SAL, dos Reis MA, de Paula Antunes Teixeira V, Rodrigues Júnior V. High levels of interleukin-1 in patients with endemic pemphigus foliaceus. Clin Diagn Lab Immunol. 2003;10:741-43. (Pubitemid 37129480)
15. Takahashi H, AmagaiM, Tanikawa A, Suzuki S, Ikeda Y, Nishikawa T, et al. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J Invest Dermatol. 2007;127:324-30. (Pubitemid 46106910)
16. Stern JN, Keskin DB, Barteneva N, Zuniga J, Yunis EJ, Ahmed AR. Possible role of natural killer cells in pemphigus vulgaris - preliminary observations. Clin Exp Immunol. 2008;152:472-81. (Pubitemid 351661495)
17. Zakka LR, Fradkov E, Keskin DB, Tabansky I, Stern JN, Ahmed AR. he role of natural killer cells in autoimmune blistering diseases. Autoimmunity. 2012;45:44-54.
18. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996;132:203-12.
19. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 1996;17:245-61. (Pubitemid 26001083)
20. Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, et al. The non-ligand binding ß-isoform of the human glucocorticoid receptor (hGRß): Tissue levels, mechanism of action, and potential physiologic role. Mol Med. 1996;2:597-607. (Pubitemid 26353108)
21. Yudt MR, Cidlowski JA. The glucocorticoid receptor: Coding a diversity of proteins and responses through a single gene. J Mol Endocrinol. 2002;16:1719-26. (Pubitemid 34828083)
22. Martin LK,Werth V, Villanueva E, Segall J, Murrell DF. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev. 2009;21:37-9.
23. Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK, et al. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest. 1994;93:33-9.
24. De Antonio SR, Blotta HM, Mamoni RL, Louzada P, Bertolo MB, Foss NT, et al. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis. J Rheumatol. 2002;29:46-51. (Pubitemid 34041857)
25. Carlotti AP, Franco PB, Elias LL, Facincani I, Costa EL, Foss N, et al. Glucocorticoid receptors, in vitro steroid sensitivity, and cytokine secretion in idiopathic nephritic syndrome. Kidney Int. 2004;65:403-08. (Pubitemid 38130634)
26. De Antonio SR, Saber LTS, Chriguer RS, de Castro M. Glucocorticoid resistance in dialysis patients impairs long-term kidney allograft outcome. Nephrol Dial Transplant. 2008;23:1422-28. (Pubitemid 351767506)
27. Chriguer RS, Elias LL, da Silva Jr IM, Vieira JG, Moreira AC, de Castro M. Glucocorticoid sensitivity in young healthy individuals: In vitro and in vivo studies. J Clin Endocrinol Metab. 2005;90:5978-84. (Pubitemid 41606514)
28. Olsen NL, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med. 2004;350:2167-79.
29. Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, et al. Association glucocorticoid insensitivity whith increase expression of glucocorticoid receptor ß. J Exp Med. 1997;186:1567-74. (Pubitemid 27479816)
30. Derijk RH, Schaaf M, De Kloet ER. Glucocorticoid receptor variants: Clinical implications. J Steroid Biochem Mol Biol. 2002;81:103-22. (Pubitemid 34879139)
31. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: Population based cohort study. BMJ. 2008;337:160-63. (Pubitemid 352039867)
32. Rocha-Alvarez R, Ortega-Loayza AG, Friedman H, Campbell I, Aoki V, Rivitti EA, et al. Cooperative Group on Fogo Selvagem Research. Endemic pemphigus vulgaris. Arch Dermatol. 2007;143:895-99.
33. Ahmed AR, Sami N. Uncommon manifestations of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2002;16:313-15.
34. Suárez-Fernández R, España-Alonso A, Herrero-González JE, Mascaró-Galy JM. Practical management of the most common autoimmune bullous diseases. Actas Dermosifiliogr. 2008;99:441-55.
35. Prajapati V, Mydlarski PR. Advances in pemphigus therapy. Skin Therapy Lett. 2008;13:4-7.
36. Singh S, Chaudhary R. Pulse therapy for pemphigus: The burden of proof. Indian J Dermatol Venereol Leprol. 2009;75:82-4.
37. Horváth B, Huizinga J, Pas HH, Mulder AB, Jonkman MF. Low-dose rituximab is effective in pemphigus. Br J Dermatol. 2012;166:405-12.
38. Behzad M, Möbs C, Kneisel A, Moeller M, Hoyer J, Hertl M, et al. Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remissions in difficult to treat pemphigus. Br J Dermatol. 2011; Nov 16. doi:10.1111/j.1365-2133.2011.10732.x. [Epub ahead of print].
39. Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T, et al. Expression of glucocorticoid receptor in lymphocytes of patients with glucocorticoid- resistant ulcerative colitis. Gastroenterology. 2000;118:859-66. (Pubitemid 30243749)
40. Oakley RH, Sar M, Cidlowisk JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem. 1999;271:9550-59.
41. Goecke A, Guerrero J. Glucocorticoid receptor beta in acute and chronic inflammatory conditions: Clinical implications. Immunobiology. 2006;211:85-96. (Pubitemid 43150110)
42. Zeoti DM, Figueiredo JFC, Chiossi MPV, Roselino AM. Serum cytokines in patients with Brazilian pemphigus foliaceus (fogo selvagem). Braz J Med Biol Res. 2000;33:1065-68.
43. Baroni A, Perfetto B, Ruocco E, Greco R, Criscuolo D, Ruocco V. Cytokine pattern in blister fluid and sera of patients with pemphigus. Dermatology. 2002;205:116-21.
44. López-Robles E, Avalos-Díaz E, Vega-Memije E, Hojyo-Tomoka T, Villalobos R, Fraire S, et al. TNFa and IL-6 are mediators in the blistering process of pemphigus. Inter J Dermatol. 2001;40:185-88. (Pubitemid 32586277)
45. Rodrigues DB, Pereira SA, dos Reis MA, Adad SJ, Caixeta JE, Chiba AM, et al. In situ detection of inflammatory cytokines and apoptosis in pemphigus foliaceus patients. Arch Pathol Lab Med. 2009;133:97-100.
46. Keskin DB, Stern JN, Fridkis-Hareli M. Razzaque Ahmed A. Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy. Cytokine. 2008;41:315-21.